San Diego, CA, United States of America

Elissa Keogh



 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 97(Granted Patents)


Company Filing History:


Years Active: 2003-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Elissa Keogh: Innovator in Respiratory Virus Antibodies

Introduction

Elissa Keogh is a prominent inventor based in San Diego, California. She has made significant contributions to the field of medical science, particularly in the development of antibodies targeting respiratory viruses. With a total of six patents to her name, her work has the potential to impact the treatment and prevention of viral infections.

Latest Patents

Among her latest patents is a groundbreaking innovation related to Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use. This patent provides antibodies or antigen-binding fragments that specifically bind to the fusion (F) protein of RSV. The methods outlined in this patent focus on the prevention, treatment, and diagnosis of viral infections, as well as addressing symptoms associated with RSV-mediated diseases. Additionally, the patent includes methods for generating antibodies that immunospecifically bind to the RSV F protein.

Career Highlights

Elissa has worked with notable companies in the biotechnology sector, including Crucell Holland B.V. and Epimmune Inc. Her experience in these organizations has allowed her to develop her expertise in antibody research and viral disease treatment.

Collaborations

Elissa has collaborated with esteemed colleagues such as Robert Anthony Williamson and Jehangir Wadia. These partnerships have further enriched her research and contributed to her innovative work in the field.

Conclusion

Elissa Keogh's contributions to the development of antibodies against respiratory viruses highlight her role as a leading inventor in medical science. Her patents and collaborations reflect her commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…